SNARE-dependent glutamate release in megakaryocytes

Experimental Hematology

Volumn 38, Issue 6, 2010, Pages 504-515

  Thompson, Catherine J ^a   Schilling, Tatjana ^a   Howard, Martin R ^b   Genever, Paul G ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b National Health Service Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; GLUTAMIC ACID; SNARE PROTEIN; SYNAPTOBREVIN; SYNTAXIN; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL LINE; CELL VACUOLE; CONTROLLED STUDY; DNA MODIFICATION; EXOCYTOSIS; FLUOROMETRY; GENE DELETION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE SECTION; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; DNA PRIMERS; EXOCYTOSIS; GLUTAMIC ACID; HUMANS; MEGAKARYOCYTES; MICE; SNARE PROTEINS;

EID: 77952954131     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.03.011     Document Type: Article

References (54)

1. de Sauvage F.J., Carver-Moore K., Luoh S.M., et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 1996, 183:651-656.
2. Kaushansky K. Thrombopoietin: the primary regulator of megakaryocyte and platelet production. Thromb Haemost 1995, 74:521-525.
3. Gordon M.S., Hoffman R. Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia. Blood 1992, 80:302-307.
4. Wendling F., Han Z.C. Positive and negative regulation of megakaryocytopoiesis. Baillieres Clin Haematol 1997, 10:29-45.
5. Zheng C., Yang R., Han Z., Zhou B., Liang L., Lu M. TPO-independent megakaryocytopoiesis. Crit Rev Oncol Hematol 2008, 65:212-222.
6. Collingridge G.L., Lester R.A. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev 1989, 41:143-210.
7. Headley P.M., Grillner S. Excitatory amino acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol Sci 1990, 11:205-211.
8. Hinoi E., Takarada T., Ueshima T., Tsuchihashi Y., Yoneda Y. Glutamate signaling in peripheral tissues. Eur J Biochem 2004, 271:1-13.
9. Skerry T.M., Genever P.G. Glutamate signalling in non-neuronal tissues. Trends Pharmacol Sci 2001, 22:174-181.
10. Genever P.G., Wilkinson D.J., Patton A.J., et al. Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood 1999, 93:2876-2883.
11. Hitchcock I.S., Skerry T.M., Howard M.R., Genever P.G. NMDA receptor-mediated regulation human megakaryocytopoiesis. Blood 2003, 102:1254-1259.
12. Hoogland G., Bos I.W., Kupper F., et al. Thrombin-stimulated glutamate uptake in human platelets is predominantly mediated by the glial glutamate transporter EAAT2. Neurochem Int 2005, 47:499-506.
13. Zoia C., Cogliati T., Tagliabue E., et al. Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease. Neurobiol Aging 2004, 25:149-157.
14. Morrell C.N., Sun H., Ikeda M., et al. Glutamate mediates platelet activation through the AMPA receptor. J Exp Med 2008, 205:575-584.
15. Murthy V.N., De Camilli P. Cell biology of the presynaptic terminal. Annu Rev Neurosci 2003, 26:701-728.
16. Sudhof T.C. The synaptic vesicle cycle. Annu Rev Neurosci 2004, 27:509-547.
17. Sollner T., Bennett M.K., Whiteheart S.W., Scheller R.H., Rothman J.E. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell 1993, 75:409-418.
18. Chen Y.A., Scheller R.H. SNARE-mediated membrane fusion. Nat Rev Mol Cell Biol 2001, 2:98-106.
19. Richmond J.E., Broadie K.S. The synaptic vesicle cycle: exocytosis and endocytosis in Drosophila and C. elegans. Curr Opin Neurobiol 2002, 12:499-507.
20. Zinsmaier K.E., Bronk P. Molecular chaperones and the regulation of neurotransmitter exocytosis. Biochem Pharmacol 2001, 62:1-11.
21. Biederer T., Sudhof T.C. Mints as adaptors. Direct binding to neurexins and recruitment of munc18. J Biol Chem 2000, 275:39803-39806.
22. Calakos N., Scheller R.H. Vesicle-associated membrane protein and synaptophysin are associated on the synaptic vesicle. J Biol Chem 1994, 269:24534-24537.
23. Gerst J.E. SNARE regulators: matchmakers and matchbreakers. Biochim Biophys Acta 2003, 1641:99-110.
24. Mochida S. Protein-protein interactions in neurotransmitter release. Neurosci Res 2000, 36:175-182.
25. Novick P., Zerial M. The diversity of Rab proteins in vesicle transport. Curr Opin Cell Biol 1997, 9:496-504.
26. Herzog E., Gilchrist J., Gras C., et al. Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience 2004, 123:983-1002.
27. Hisano S., Sawada K., Kawano M., et al. Expression of inorganic phosphate/vesicular glutamate transporters (BNPI/VGLUT1 and DNPI/VGLUT2) in the cerebellum and precerebellar nuclei of the rat. Brain Res Mol Brain Res 2002, 107:23-31.
28. Kaneko T., Fujiyama F. Complementary distribution of vesicular glutamate transporters in the central nervous system. Neurosci Res 2002, 42:243-250.
29. Drachman J.G., Rojnuckarin P., Kaushansky K. Thrombopoietin signal transduction: studies from cell lines and primary cells. Methods 1999, 17:238-249.
30. Linden H.M., Kaushansky K. The glycan domain of thrombopoietin enhances its secretion. Biochemistry 2000, 39:3044-3051.
31. Sweeney S.T., Broadie K., Keane J., Niemann H., O'Kane C.J. Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects. Neuron 1995, 14:341-351.
32. Genever P.G., Skerry T.M. Regulation of spontaneous glutamate release activity in osteoblastic cells and its role in differentiation and survival: evidence for intrinsic glutamatergic signaling in bone. FASEB J 2001, 15:1586-1588.
33. Nicholls D.G., Sihra T.S., Sanchez-Prieto J. Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J Neurochem 1987, 49:50-57.
34. Barasch J., Kiss B., Prince A., Saiman L., Gruenert D., al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature 1991, 352:70-73.
35. Kapuscinski J., Darzynkiewicz Z., Melamed M.R. Luminescence of the solid complexes of acridine orange with RNA. Cytometry 1982, 2:201-211.
36. Link E., Edelmann L., Chou J.H., et al. Tetanus toxin action: inhibition of neurotransmitter release linked to synaptobrevin proteolysis. Biochem Biophys Res Commun 1992, 189:1017-1023.
37. Robinson L.J., Martin T.F. Docking and fusion in neurosecretion. Curr Opin Cell Biol 1998, 10:483-492.
38. Ravichandran V., Chawla A., Roche P.A. Identification of a novel syntaxin- and synaptobrevin/VAMP-binding protein, SNAP-23, expressed in non-neuronal tissues. J Biol Chem 1996, 271:13300-13303.
39. Roy R., Laage R., Langosch D. Synaptobrevin transmembrane domain dimerization-revisited. Biochemistry 2004, 43:4964-4970.
40. Morimoto R., Hayashi M., Yatsushiro S., Otsuka M., Yamamoto A., Moriyama Y. Co-expression of vesicular glutamate transporters (VGLUT1 and VGLUT2) and their association with synaptic-like microvesicles in rat pinealocytes. J Neurochem 2003, 84:382-391.
41. Wojcik S.M., Rhee J.S., Herzog E., et al. An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci U S A 2004, 101:7158-7163.
42. Daniels R.W., Collins C.A., Gelfand M.V., et al. Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content. J Neurosci 2004, 24:10466-10474.
43. Zoccarato F., Cavallini L., Alexandre A. The pH-sensitive dye acridine orange as a tool to monitor exocytosis/endocytosis in synaptosomes. J Neurochem 1999, 72:625-633.
44. Betz A., Okamoto M., Benseler F., Brose N. Direct interaction of the rat unc-13 homologue Munc13-1 with the N terminus of syntaxin. J Biol Chem 1997, 272:2520-2526.
45. Fergestad T., Broadie K. Interaction of stoned and synaptotagmin in synaptic vesicle endocytosis. J Neurosci 2001, 21:1218-1227.
46. Henkel A.W., Lubke J., Betz W.J. FM1-43 dye ultrastructural localization in and release from frog motor nerve terminals. Proc Natl Acad Sci U S A 1996, 93:1918-1923.
47. Rheuben M.B., Autio D.M., Xu Y.F., Atchison W.D. Morphometric characterization of the neuromuscular junction of rodents intoxicated with 2,4-dithiobiuret: evidence that nerve terminal recycling processes contribute to muscle weakness. Toxicol Appl Pharmacol 2004, 196:266-286.
48. Takamori S., Rhee J.S., Rosenmund C., Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 2000, 407:189-194.
49. Isakari Y., Sogo S., Ishida T., et al. Gene expression analysis during platelet-like particle production in phorbol myristate acetate-treated MEG-01 cells. Biol Pharm Bull 2009, 32:354-358.
50. Mahaut-Smith M.P., Hussain J.F., Mason M.J. Depolarization-evoked Ca2+ release in a non-excitable cell, the rat megakaryocyte. J Physiol 1999, 515(Pt 2):385-390.
51. Mason M.J., Mahaut-Smith M.P. Measurement and manipulation of intracellular Ca2+ in single platelets and megakaryocytes. Methods Mol Biol 2004, 273:251-276.
52. Thomas D., Mason M.J., Mahaut-Smith M.P. Depolarisation-evoked Ca2+ waves in the non-excitable rat megakaryocyte. J Physiol 2001, 537:371-378.
53. Zamponi G.W. Regulation of presynaptic calcium channels by synaptic proteins. J Pharmacol Sci 2003, 92:79-83.
54. Bhangu P.S., Genever P.G., Spencer G.J., Grewal T.S., Skerry T.M. Evidence for targeted vesicular glutamate exocytosis in osteoblasts. Bone 2001, 29:16-23.